Vilfuro-G Inhalation Capsules

Vilfuro-G Inhalation Capsules – Advanced Dual Therapy for COPD and Asthma Management

Vilfuro-G Inhalation Capsules are a combination respiratory therapy designed for the long-term management of Chronic Obstructive Pulmonary Disease (COPD) and asthma. Each capsule contains Vilanterol and Umeclidinium, two long-acting bronchodilators that work synergistically to provide effective, 24-hour relief from breathing difficulties and enhanced lung function.

Vilfuro-G offers dual bronchodilation through a unique combination of:

• Vilanterol (LABA) – a long-acting β2-adrenergic receptor agonist that helps relax airway muscles for easier breathing.

• Umeclidinium (LAMA) – a long-acting muscarinic antagonist that prevents airway constriction by blocking acetylcholine receptors.

This combination provides once-daily dosing convenience, sustained symptom control, and improved quality of life for patients suffering from COPD and other chronic respiratory diseases.

• Provides 24-hour bronchodilation with once-daily use

• Improves airflow and lung function

• Reduces breathlessness, coughing, and chest tightness

• Decreases frequency of exacerbations in COPD patients

• Enhances daily activity performance and respiratory comfort

Each inhalation capsule contains:

• Vilanterol Trifenatate – Long-acting β2 agonist (LABA)

• Umeclidinium Bromide – Long-acting muscarinic antagonist (LAMA)

(Dosage strength may vary as per physician’s prescription.)

• Chronic Obstructive Pulmonary Disease (COPD)

• Chronic Bronchitis

• Emphysema

• Maintenance treatment for long-term respiratory disorders

(Not indicated for acute asthma attacks or emergency treatment.)

• Recommended for inhalation use only, via a compatible inhalation device.

• Typically one capsule daily, or as prescribed by the physician.

• Do not swallow the capsules.

• For consistent benefits, use the medication regularly at the same time each day.

• Vilanterol relaxes airway smooth muscles through β2 receptor stimulation, improving airflow.

• Umeclidinium inhibits muscarinic receptors to prevent bronchoconstriction.
  Together, they deliver dual bronchodilation, ensuring continuous and stable respiratory function throughout the day.

The Vilanterol + Umeclidinium combination is marketed worldwide under brands such as Anoro Ellipta, Vilfuro-G, and similar formulations used for COPD maintenance therapy.

Orders for Vilfuro-G Inhalation Capsules are shipped within 48 hours of payment confirmation. The product is carefully packaged to maintain stability and safety during international transport.

Reliable global shipping through DHL, FedEx, UPS, EMS, Aramex, India Post, and Delhivery, ensuring timely and trackable delivery worldwide.

• Wire / Bank Transfer

• Telegraphic Transfer (TT)

• Western Union

• Ria Money Transfer

This description is provided for informational and B2B trade purposes. Always use Vilfuro-G under the guidance of a licensed healthcare provider and only with the recommended inhalation device.

Prices may vary based on order quantity, region, and packaging specifications. For bulk purchase inquiries, dealer pricing, or export quotations, please contact the supplier directly via official communication channels.